High materiality8/10
Nurix Therapeutics price target raised to $45 from $41 at Jefferies
Why it may matterVerify against the original reporting
bullish_upgrade
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies raises Nurix price target to $45 from $41; current price $15.56; substantial upside.
- PT $45; price $15.56; upside substantial.
Key facts
- 01
Target: $45
- 02
Posted price: $15.56
- 03
Analyst firm: Jefferies
- 04
Analyst: Roger Song
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.